Evidence map›Paper›PMID 26541886›Full record

ReviewProgress in retinal and eye research2016

Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.

Paul S Bernstein, Binxing Li, Preejith P Vachali, Aruna Gorusupudi, Rajalekshmy Shyam, Bradley S Henriksen, John M Nolan

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Progress in retinal and eye research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 252 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
252citing papers in PubMed, 6 pooled it
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04779411 completednot on this mapstarted 2020, after this paper: background citation

Validation of a Lutein and Zeaxanthin Food Frequency Questionnaire, and an Electronic Device Use Questionnaire.

TypeobservationalSponsorThe University of QueenslandRan2020 to 2022Enrolled183ConditionsLutein and Zeaxanthin Dietary Intake, Age Related Macular Degeneration, Blue Light Exposure, Electronic Device UseArmsWeekly Food Frequency Questionnaire, Monthly Food Frequency Questionnaire, 24-Hour Diet Recall, Electronic Device Use Questionnaire, 24-Hour Electronic Device Use Diary
NCT04786392 phase1withdrawnnot on this mapstarted 2021, after this paper: background citation

Lutein Absorption Consumed as Supplement, Blended Food, or Wholefood Over 24-hours.

TypeinterventionalSponsorThe University of QueenslandRan2021 to 2021Enrolled0ConditionsMacula Lutea OpacityArmsLutein supplement, Food, blended, Food, unprocessed
3 · Its place in the literature

Who cites it

252 citing papers in PubMed, 6 syntheses or guidelines pooled it, 526 citations in OpenAlex.

  1. Pooled it
  2. Passion fruit (Frontiers in nutrition · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Protective effects ofHistology and histopathology · 2026
    Article
  16. Lute-GenAntioxidants (Basel, Switzerland) · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Bioactive potential of biomass and lipids of halophilic cyanobacterium and microalgae.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article

192 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Paul S BernsteinDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, UT, 84132, USA. Electronic address: paul.bernstein@hsc.utah.edu.
Binxing LiDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, UT, 84132, USA. Electronic address: binxing.li@hsc.utah.edu.
Preejith P VachaliDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, UT, 84132, USA. Electronic address: preejith.vachali@hsc.utah.edu.
Aruna GorusupudiDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, UT, 84132, USA. Electronic address: aruna.gorusupudi@utah.edu.
Rajalekshmy ShyamDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, UT, 84132, USA. Electronic address: r.shyam@utah.edu.
Bradley S HenriksenDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, UT, 84132, USA. Electronic address: brad.henriksen@hsc.utah.edu.
John M NolanMacular Pigment Research Group, Vision Research Centre, School of Health Science, Carriganore House, Waterford Institute of Technology West Campus, Carriganore, Waterford, Ireland. Electronic address: jmnolan@wit.ie.
University of Utah · USWaterford Institute of Technology · IE

Funding

University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Bryan William Jones · 2005 to 2026
$14.6M
Biochemistry and Pharmacology of the Macular CarotenoidsR01EY011600 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI BERNSTEIN, PAUL STEVEN · 2004 to 2025
$7.7M
Retinal RemodelingR01EY015128 · NEI · UNIVERSITY OF UTAH · PI JONES, BRYAN WILLIAM · 2004 to 2021
$7.0M
Short-Term Training: Students in Health Professional SchoolsT35HL007744 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS, TRISTANI-FIROUZI, MARTIN · 1993 to 2025
$3.1M
Vision Research Training Grant at the University of UtahT32EY024234 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI DAVID KRIZAJ, Monica L Vetter · 2014 to 2026
$2.3M
BIOCHEMISTRY AND PHARMACOLOGY OF THE MACULAR CAROTENOIDSR29EY011600 · NEI · UNIVERSITY OF UTAH · PI BERNSTEIN, PAUL STEVEN · 1997 to 2001
$209k
NEI NIH HHS EY-11600NEI NIH HHS EY-14800NEI NIH HHS P30 EY014800NEI NIH HHS R01 EY011600NEI NIH HHS R01 EY015128NEI NIH HHS R29 EY011600NEI NIH HHS T32 EY024234NHLBI NIH HHS T35 HL007744
6 · The paper itself

Abstract

The human macula uniquely concentrates three carotenoids: lutein, zeaxanthin, and meso-zeaxanthin. Lutein and zeaxanthin must be obtained from dietary sources such as green leafy vegetables and orange and yellow fruits and vegetables, while meso-zeaxanthin is rarely found in diet and is believed to be formed at the macula by metabolic transformations of ingested carotenoids. Epidemiological studies and large-scale clinical trials such as AREDS2 have brought attention to the potential ocular health and functional benefits of these three xanthophyll carotenoids consumed through the diet or supplements, but the basic science and clinical research underlying recommendations for nutritional interventions against age-related macular degeneration and other eye diseases are underappreciated by clinicians and vision researchers alike. In this review article, we first examine the chemistry, biochemistry, biophysics, and physiology of these yellow pigments that are specifically concentrated in the macula lutea through the means of high-affinity binding proteins and specialized transport and metabolic proteins where they play important roles as short-wavelength (blue) light-absorbers and localized, efficient antioxidants in a region at high risk for light-induced oxidative stress. Next, we turn to clinical evidence supporting functional benefits of these carotenoids in normal eyes and for their potential protective actions against ocular disease from infancy to old age.

Indexed as

AnimalsAntioxidantsDietEye DiseasesHaplorhiniHumansLuteinMacula LuteaMacular DegenerationRetinal PigmentsZeaxanthinsAntioxidantsLuteinmeso-zeaxanthinRetinal PigmentsZeaxanthinsAge-related macular degenerationCarotenoidLuteinMacular pigmentNutritionZeaxanthin

Identifiers

PMID26541886
PMCPMC4698241
OpenAlexW1948539164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.